Carestream Molecular Imaging Expands Global Presence

Carestream Health, Inc.Carestream Molecular Imaging, a division of Carestream Health, Inc., is expanding its international presence with new dealer partnerships and a growing worldwide customer base. The company announced several new European dealer relationships and a host of recent customer wins.

New dealer partners in Europe and the Middle East include BioNova Cientifica, S.l. in Spain, Biosense S.R.L. in Italy, Csertex KFT in Hungary, and TransOrient Trading Co. in Palestine.

"Delivering our proven molecular imaging solutions to research institutions globally, in collaboration with best-of-breed partners, is a logical extension of our international strategy," said John DelliSanti, President of Carestream Molecular Imaging. "The demand for a cost effective and translatable molecular imaging solution is growing rapidly. We intend to significantly increase our international efforts and expect to achieve continued growth and expansion into new markets around the globe."

The company's European dealer network is dedicated to increasing the presence of the company's optical molecular imaging systems and fluorescent imaging agents to prominent pharmaceutical companies and research institutions. Partners such as Advanced Molecular Vision Ltd., AMV Germany, BioTech a.s., Csertex Ltd., Metis Biyoteknoloji and Metis-Turkey have been instrumental in the company's recent customer successes in the following European institutions:

  • Baxter AG
  • Charles University of Prague, Ege University School of Medicine, Tulay Aktas Oncology Hospital
  • Humboldt Universität Berlin
  • Hungarian Academy of Sciences' Institute of Experimental Medicine
  • Imperial College London's Kennedy Institute of Rheumatology
  • Institute for Molecular Pathology IMP Istanbul University
  • Department of Molecular Biology Istanbul University Faculty of Medicine
  • University of Debrecen's Department of Physiology
  • University of Dundee's Division of Molecular Physiology
  • University of Edinburgh's MRC Centre for Inflammation Research

Carestream Molecular Imaging is showcasing its portfolio of in vivo digital molecular imaging systems and imaging agents at the 2008 World Molecular Imaging Conference.

Carestream Health, an independent company, has licensed the KODAK brand for use with its own brands across its portfolio of leading-edge molecular imaging, medical imaging and healthcare IT products.

Related news articles:

About Carestream Molecular Imaging
Carestream Molecular Imaging group, a division of Carestream Health, Inc., develops and markets high performance digital imaging systems, imaging agents, film and accessories under the KODAK brand for the life science research and drug discovery/development market segments. For more information, visit www.carestreamhealth.com/molecular-imaging.html.

About Carestream Health, Inc.
Carestream Health, Inc. is a leading provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging solutions for the life science research and drug discovery/development market segments; and x-ray film and digital x-ray products for the non-destructive testing market. The company emerged in 2007 when Onex Corporation (TSX: OCX) of Toronto, Canada, purchased Eastman Kodak Company’s Health Group. For more information about Carestream Health, contact your Carestream Health representative or visit www.carestreamhealth.com.

KODAK is a trademark of Kodak used under license.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...